Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
- PMID: 26758760
- DOI: 10.1016/S1470-2045(15)00543-4
Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources